Start Date
September 8, 2022
Primary Completion Date
October 31, 2024
Study Completion Date
January 31, 2029
Genetic HMI-203
HMI-203 delivered intravenously
Lysosomal and Rare Disorders Research and Treatment Center, Inc., Fairfax
University of Utah Pediatric Genetic & Metabolism Clinic, Salt Lake City
UCSF Benioff Children's Hospital Oakland, Oakland
Yale Center for Clinical Investigation, New Haven
Hackensack University Medical Center, Hackensack
M.A.G.I.C. Clinic, Ltd., Calgary
Lead Sponsor
Homology Medicines, Inc
INDUSTRY